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GENERAL COMMENTS
Perhaps a journal better fitted to accept this paper would be a journal which deals with medical hypotheses
The paper is interesting. However, the hypothesis of a pathophysiological role of hyperuricemic inflammation should be better stated. I would suggest to better highlight that gout, but not hyperuricemia, has been shown to represent a risk factor for all-cause and cardiovascular mortality. In this setting, it has been found that a plausible pathophysiologic mechanism might be related to inflammation, which represents the characteristic difference between gout and hyperuricemia. Indeed, it is well known that hyperuricemia and/or crystal deposition are not sufficient to cause gouty attacks. It has been proposed that iron may represent a factor which triggers inflammation and heightens inflammation, and in particular cardiovascular risk in gouty patients. Accumulating evidence suggests that gout is a disease of iron overload, and that uric acid accumulation, as both an antioxidant and an iron chelator, is in response to the iron overload. 
The authors describe interesting and intriguing findings that have a potential implication in the role of uric acid on the pathogenesis of CVD and prostatitis. While the lack of clinical correlation is a limitation, I agree with the authors' suggestion that the prevalences in these tissues are valuable in their own right, particularly for future larger-scale prospective studies.
I have provided minor comments below for the authors' consideration.
